The current pregnant women living with hiv antiretroviral therapy coverage for pmtct in Guatemala is 44%, which has increased by 5% (12.8%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Guatemala
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Guatemala
PMTCT antiretroviral therapy coverage
More indicators for Guatemala
Male unintentional poisoning
2.3
0.0
(2019)
Female wasting in children
0.6%
+0.2%
(2021)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar406
+intl dollar93
(2021)
Birth registration
96.4%
-0.3%
(2015)
Contraceptive modern method prevalence
48.9%
+4.9%
(2015)
Guatemala PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 44% | +5% |
| 2021 | 39% | +4% |
| 2020 | 35% | +1% |
| 2019 | 34% | 0% |
| 2018 | 34% | +7% |
| 2017 | 27% | +1% |
| 2016 | 26% | +6% |
| 2015 | 20% | -13% |
| 2014 | 33% | -4% |
| 2013 | 37% | +14% |
| 2012 | 23% | -8% |
| 2011 | 31% | +7% |
| 2010 | 24% | -11% |
| 2009 | 35% | +10% |
| 2008 | 25% | -3% |
| 2007 | 28% | -1% |
| 2006 | 29% | +26% |
| 2005 | 3% | +1% |
| 2004 | 2% | 0% |
| 2003 | 2% | 0% |
| 2002 | 2% | 0% |
| 2001 | 2% | +1% |
| 2000 | 1% |